acquired
Stage
4
Investors
About
Apellis Pharmaceuticals develops therapies targeting the complement system to treat a range of debilitating diseases.
Explore Apellis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.